Dr. Amy Armstrong, MD
Claim this profileWashington University School of Medicine
Studies Tumors
Studies Osteosarcoma
26 reported clinical trials
58 drugs studied
About Amy Armstrong, MD
Education:
- Received an MD from Washington University School of Medicine.
Experience:
- Serves as a Pediatric Oncologist at Washington University Physicians, with a focus on oncology and pediatric cancer.
- Practices at St. Louis Children's Hospital and St. Louis Children's Specialty Care Center – West County.
- Engaged in providing a comprehensive range of clinical services, including access to innovative treatments and clinical trials.
- Collaborates with a school liaison to support the educational needs of patients during their treatment journey.
Area of expertise
1Tumors
Stage IV
Stage I
Stage II
2Osteosarcoma
Stage IV
HLA-A positive
MAGE-A4 positive
Affiliated Hospitals
Clinical Trials Amy Armstrong, MD is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
More about Amy Armstrong, MD
Clinical Trial Related1 year of experience running clinical trials · Led 26 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Amy Armstrong, MD has experience with
- Carboplatin
- Cyclophosphamide
- Paclitaxel
- Etoposide
- Gemcitabine
- Pembrolizumab
Breakdown of trials Amy Armstrong, MD has run
Tumors
Osteosarcoma
Cancer
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amy Armstrong, MD specialize in?
Amy Armstrong, MD focuses on Tumors and Osteosarcoma. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage I.
Is Amy Armstrong, MD currently recruiting for clinical trials?
Yes, Amy Armstrong, MD is currently recruiting for 11 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Amy Armstrong, MD has studied deeply?
Yes, Amy Armstrong, MD has studied treatments such as Carboplatin, Cyclophosphamide, Paclitaxel.
What is the best way to schedule an appointment with Amy Armstrong, MD?
Apply for one of the trials that Amy Armstrong, MD is conducting.
What is the office address of Amy Armstrong, MD?
The office of Amy Armstrong, MD is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.